Rapid Micro Biosystems

Update in progress

RPID (NasdaqCM)

Company RatingNeutral
SectorHealthcare
IndustryMedical Devices

Rapid Micro Biosystems is a life sciences technology company providing automated microbial contamination testing for pharma, biologics, medical devices, and personal care products. Its Growth Direct platform combines a handling system, proprietary consumables, LIMS integration software, and support to modernize MQC workflows for biologics, cell and gene therapies, vaccines, and sterile injectables. It also offers RMBNucleus Mold Alarm, Growth Direct LIMS, onsite training, and environmental, bioburden, and sterility testing. Based in Lexington, MA.

Company score

Sentiment: 0.45; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: 0.01; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: 0.06; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: 0.12; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: 0.05; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: 0.25; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive